FAS and melanoma: We then engineered the melanoma cell lines with loss-of-function alterations (BAX or FAS knockdown or over-expression of a dominant-negative DFFA [DFFA-cleavage-resistant [CR]]50) that mimic deletions of pro-apoptotic genes, testing one gene at a time.